Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...

A woman who survived cervical cancer says she is concerned about changes to cervical screening that come into effect today.

Low screening coverage, late diagnoses, high HIV prevalence, and limited access to treatment and vaccines are driving cervical cancer cases and deaths in South Africa. The country has a cervical ...

According to the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in UNICEF & PAHO tenders in other markets.

Jiangsu Recbio Technology Company Limited, a leading Chinese biopharmaceutical company, today announced they have entered into a licensing cooperation agreement, and commenced the technology transfer ...

According to the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in ...

The US Secretary of Health and Human Services insists he will soon announce the "cause" of autism, but setting a fixed ...

The implementation of these three key pillars — vaccination, screening, and treatment — are critical in eliminating cervical ...

BE to produce and commercialise Recbio's nine-valent HPV vaccine in India and global markets, including participation in ...

A growing number of oncologists across India have expressed concern over Human Papillomavirus (HPV) becoming a major ...

With increasing cases of cervical, oral, and oropharyngeal cancers linked to HPV infection, experts believe India is on the brink of a preventable cancer crisis ...